Clinical Trial Update: Adacel® Booster Vaccination for CMI Assay Development [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Adacel booster vaccination for CMI assay development in pertussis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pertussis

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))

Snippet

Sponsor: Dalhousie University | Conditions: Pertussis | Phase 4 | Status: COMPLETED